IN2013MU03765A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU03765A IN2013MU03765A IN3765MU2013A IN2013MU03765A IN 2013MU03765 A IN2013MU03765 A IN 2013MU03765A IN 3765MU2013 A IN3765MU2013 A IN 3765MU2013A IN 2013MU03765 A IN2013MU03765 A IN 2013MU03765A
- Authority
- IN
- India
- Prior art keywords
- atorvastatin calcium
- compositions
- density lipoprotein
- lipoprotein cholesterol
- faster
- Prior art date
Links
- OJRHUICOVVSGSY-RXMQYKEDSA-N (2s)-2-chloro-3-methylbutan-1-ol Chemical group CC(C)[C@H](Cl)CO OJRHUICOVVSGSY-RXMQYKEDSA-N 0.000 abstract 3
- 229960001770 atorvastatin calcium Drugs 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 108010023302 HDL Cholesterol Proteins 0.000 abstract 2
- 108010028554 LDL Cholesterol Proteins 0.000 abstract 2
- 230000003381 solubilizing effect Effects 0.000 abstract 2
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000002687 nonaqueous vehicle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3765MU2013 IN2013MU03765A (enExample) | 2013-11-30 | 2013-11-30 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3765MU2013 IN2013MU03765A (enExample) | 2013-11-30 | 2013-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU03765A true IN2013MU03765A (enExample) | 2015-07-31 |
Family
ID=54398014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3765MU2013 IN2013MU03765A (enExample) | 2013-11-30 | 2013-11-30 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013MU03765A (enExample) |
-
2013
- 2013-11-30 IN IN3765MU2013 patent/IN2013MU03765A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ780890A (en) | Pharmaceutical compositions comprising meloxicam | |
| NZ631100A (en) | Soft chewable pharmaceutical products | |
| EA201892395A1 (ru) | Лекарственные составы ингибитора lsd1 | |
| WO2013188792A3 (en) | Neuroactive steroids, compositions, and uses thereof | |
| MY178082A (en) | Solid pharmaceutical compositions and processes for their production | |
| WO2010127345A3 (en) | Orally disintegrating tablet compositions comprising combinations of high and low-dose drugs | |
| EA201500365A1 (ru) | Комбинация регорафениба и ацетилсалициловой кислоты для лечения рака | |
| MX2017010280A (es) | Complejos de acetato de abiraterona, proceso para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
| HK1215191A1 (zh) | 低剂量医药组合物 | |
| WO2019155416A3 (en) | A stable pharmaceutical composition of poorly soluble nonsteroidal antiandrogens | |
| WO2014016754A3 (en) | Pharmaceutical compositions of proton pump inhibitor | |
| WO2012116176A3 (en) | Asymmetric ureas and medical uses thereof | |
| WO2011151722A3 (en) | Methods and compositions for oral pharmaceutical therapy | |
| HK1208222A1 (en) | Modified release formulations for oprozomib | |
| PH12015500395A1 (en) | Pharmaceutical composite capsule formulation comprising irbesartan and hmg-coa reductase inhibitor | |
| EP3615011A4 (en) | PHARMACEUTICAL COMPOSITION FOR IN VIVO ADMINISTRATION, PROCESS FOR THE PREPARATION OF A PHARMACOLOGICALLY ACTIVE PRINCIPLE SENSITIVELY INSOLUBLE IN WATER | |
| WO2011083402A3 (en) | Immediate release compositions of acid labile drugs | |
| MX364652B (es) | Formulacion farmaceutica que comprende ciclesonida. | |
| MX2016007741A (es) | Preparacion de combinacion farmaceutica que comprende un inhibidor de hmg-coa reductasa y un inhibidor de la absorcion de colesterol. | |
| GR1008821B (el) | Φαρμακευτικο σκευασμα που περιλαμβανει υδροχλωρικη ιβαμπραδινη και μεθοδος παρασκευης αυτου | |
| IN2014CN02343A (en) | Oral formulations containing hyaluronic acid for sustained drug release | |
| WO2014125504A3 (en) | Pharmaceutical compositions of febuxostat | |
| IN2013MU03765A (enExample) | ||
| MX2015015681A (es) | Composicion farmaceutica que comprende fingolimod. | |
| WO2014119984A3 (es) | Composición farmacéutica con un sistema bifásico de liberación inmediata para el control de eventos convulsivos y del dolor |